HomeNTRA • NASDAQ
add
Natera Inc
Nakaraang pagsara
$168.32
Sakop ng araw
$166.58 - $170.94
Sakop ng taon
$53.88 - $171.95
Market cap
22.03B USD
Average na Volume
1.37M
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
Sa balita
Mga Financial
Income Statement
Kita
Net na kita
| (USD) | Set 2024info | Y/Y na pagbabago |
|---|---|---|
Kita | 439.76M | 63.90% |
Gastos sa pagpapatakbo | 311.08M | 34.10% |
Net na kita | -31.59M | 71.02% |
Net profit margin | -7.18 | 82.33% |
Kita sa bawat share | -0.26 | 72.63% |
EBITDA | -31.14M | 70.06% |
Aktuwal na % ng binabayarang buwis | -2.37% | — |
Balance Sheet
Kabuuang asset
Kabuuang sagutin
| (USD) | Set 2024info | Y/Y na pagbabago |
|---|---|---|
Cash at mga panandaliang investment | 922.33M | -1.52% |
Kabuuang asset | 1.59B | 9.98% |
Kabuuang sagutin | 712.42M | 7.64% |
Kabuuang equity | 878.52M | — |
Natitirang share | 132.02M | — |
Presyo para makapag-book | 23.77 | — |
Return on assets | -6.33% | — |
Return on capital | -7.48% | — |
Cash Flow
Net change in cash
| (USD) | Set 2024info | Y/Y na pagbabago |
|---|---|---|
Net na kita | -31.59M | 71.02% |
Cash mula sa mga operasyon | 51.79M | 274.37% |
Cash mula sa pag-invest | 42.54M | -47.67% |
Cash mula sa financing | 1.72M | -99.27% |
Net change in cash | 96.05M | -66.60% |
Malayang cash flow | 40.19M | 1,066.44% |
Tungkol
Natera, Inc. is a clinical genetic testing company based in Austin, Texas that specializes in non-invasive, cell-free DNA testing technology, with a focus on women’s health, cancer, and organ health. Natera’s proprietary technology combines novel molecular biology techniques with a suite of bioinformatics software that allows detection down to a single molecule in a tube of blood. Natera operates CAP-accredited laboratories certified under the Clinical Laboratory Improvement Amendments in San Carlos, California and Austin, Texas. Wikipedia
Itinatag
Ene 1, 2004
Headquarters
Website
Mga Empleyado
3,288
